openPR Logo
Press release

Global Spinal Implants Market to Grow at a CAGR of 5.50% Through 2032, Fueled by Aging Population, Degenerative Disorders, and Technological Innovation | DelveInsight

07-04-2025 03:43 PM CET | Health & Medicine

Press release from: DelveInsight

Global Spinal Implants Market

Global Spinal Implants Market

The spinal implants market is steadily expanding, driven by the increasing prevalence of degenerative spinal conditions, spinal injuries, deformities, and age-related disorders such as osteoporosis. With rising demand for motion-preserving and minimally invasive solutions, the market is undergoing a significant transformation shaped by advanced material science and surgical techniques.

Spinal implants play a pivotal role in stabilizing the spine, correcting deformities, and promoting spinal fusion after trauma or disease. The market comprises fusion implants (pedicle screws, rods, cages), non-fusion devices (artificial discs, dynamic stabilization systems), and minimally invasive systems. Technological advancements in 3D-printed, bioresorbable, and titanium-coated implants are enhancing integration, reducing complications, and improving patient mobility post-surgery.

DelveInsight's Spinal Implants Market Insights, Competitive Landscape, and Market Forecast - 2032 provides an in-depth analysis of market dynamics across key geographies, including the US, EU4 (Germany, France, Italy, Spain), the UK, Japan, and others. The report explores the market by device type, indication (trauma, degenerative disc disease, scoliosis, etc.), approach (anterior, posterior, lateral), and healthcare setting.

Top players such as Zimmer Biomet, Medtronic plc., Johnson & Johnson Services, Inc., Stryker Corporation, B. Braun Melsungen AG, NuVasive®, Inc., and Orthofix Medical Inc., are investing in robotics integration, image-guided navigation, and patient-specific implant technologies. These innovations are redefining spine surgery with improved precision, faster recovery times, and better long-term outcomes.

As global awareness around spinal health grows and surgical tools continue to evolve, the spinal implants market is poised for robust growth, focusing on patient safety, long-term performance, and customized care delivery.

Explore the latest trends and growth drivers in the spinal implants market-download your sample report now https://www.delveinsight.com/report-store/spinal-implants-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr

Key Takeaways from the Spinal Implants Market Report
• The global spinal implants market was valued at USD 14.32 billion in 2024 and is projected to grow at a 5.5% CAGR, reaching USD 21.9 billion by 2032.
• As per DelveInsight estimates, North America is anticipated to dominate the global spinal implants market during the forecast period.
• Notable spinal implants companies such as Zimmer Biomet, Medtronic plc., Johnson & Johnson Services, Inc., Stryker Corporation, B. Braun Melsungen AG, NuVasive®, Inc., Orthofix Medical Inc., XTANT MEDICAL, RTI Surgical, Life Spine, Inc., Globus Medical, Captiva Spine, Inc., Medacta International, ATEC Spine, Inc., Advin Health Care, Auxein Medical, Aurora Spine, Spineology Inc., Camber Spine Technologies, LLC, Exactech, Inc., and several others are currently operating in the spinal implants market.
• In May 2025, Neuralink announced that it has received the FDA's "breakthrough" designation for its device aimed at restoring communication for individuals with severe speech impairment. The device, designed to assist patients with conditions like amyotrophic lateral sclerosis (ALS), stroke, spinal cord injury, cerebral palsy, and multiple sclerosis, represents a significant step forward in neurotechnology.
• In January 2025, Life Spine, Inc., a medical device company specializing in spinal disorder treatments, announced that it has received clearance from the U.S. Food & Drug Administration (FDA) to market its ProLift Pivot Expandable Spacer System.
• In January 2025, Stryker, a global leader in medical technologies, announced a definitive agreement to sell its U.S. spinal implants business to Viscogliosi Brothers, LLC, a family-owned investment firm specializing in the neuro-musculoskeletal space, to create a newly formed company called VB Spine, LLC.
• In January 2024, Providence Medical Technology, Inc. received FDA clearance for its CAVUX® FFS-LX: Lumbar Facet Fixation System, designed for use in lumbar spinal fusion surgery.

To read more about the latest highlights related to the spinal implants market, get a snapshot of the key highlights entailed in the global spinal implants market report here https://www.delveinsight.com/report-store/spinal-implants-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr

Spinal Implants Overview
Spinal implants are medical devices used to treat various spinal conditions, including degenerative disc disease, spinal fractures, scoliosis, and spondylolisthesis. These implants help stabilize the spine, promote fusion between vertebrae, or preserve motion, depending on the type and purpose of the device. Common types of spinal implants include rods, screws, plates, interbody cages, and artificial discs. Made from materials like titanium, stainless steel, and PEEK, they offer durability and biocompatibility. Advances in minimally invasive surgery, 3D printing, and biologically active coatings have enhanced implant precision and patient outcomes. As spinal disorders rise globally, especially among aging populations, the demand for effective and long-lasting spinal implants continues to grow.

Spinal Implants Market Insights
North America is projected to lead the spinal implants market in 2024, driven by the high prevalence of spinal disorders, advanced healthcare infrastructure, and strong presence of key players. The region benefits from the rapid adoption of innovative technologies, favorable reimbursement policies, and a growing volume of spinal surgeries.

According to the American Association of Neurological Surgeons (2024), about 450,000 people in the U.S. are living with spinal cord injuries (SCIs), with around 17,000 new cases each year. Additionally, a 2022 NIH study reported approximately 1.6 million spinal surgeries in North America, highlighting the rising demand for spinal implants due to trauma-related spinal injuries.

Product innovations also support market growth. For example, in September 2023, ZimVie Inc. received FDA approval to begin a U.S. trial for its Mobi-C® Cervical Disc Hybrid system, further strengthening its market position.
These factors collectively position North America as the dominant region in the spinal implants market.

To know more about why North America is leading the market growth in the spinal implants market, get a snapshot of the spinal implants market outlook here https://www.delveinsight.com/report-store/spinal-implants-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr

Spinal Implants Market Dynamics
According to the World Health Organization (2024), over 15 million people worldwide live with spinal cord injuries (SCIs), often caused by road accidents, falls, or sports injuries. These cases typically require surgical intervention, where spinal implants play a vital role in stabilizing the spine and aiding recovery. The rising incidence of such injuries, combined with the growing demand for minimally invasive solutions, is driving market growth.

Low back pain is another major contributor to the spinal implant market. WHO (2023) reported that 619 million people globally were affected by low back pain in 2020, a number expected to reach 843 million by 2050. Structural issues and nerve compression often necessitate surgical intervention, further increasing the demand for spinal implants.

Additionally, increased R&D and innovation are propelling the market forward. Companies are developing next-gen implants using technologies like 3D printing, AI, and bioactive coatings. For instance, in December 2024, Carlsmed received FDA 510(k) clearance for its AI-enabled aprevo® Cervical ACDF Interbody System, highlighting the shift toward personalized spine surgery.

Despite this progress, the market faces challenges such as surgical complications, revision risks, and stringent regulatory pathways, which can delay approvals and add to development costs. However, the overall outlook for the spinal implant market remains positive through 2032.

Get a sneak peek at the spinal implants market dynamics @ https://www.delveinsight.com/report-store/spinal-implants-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr

Coverage: Global
Study Period: 2022 to 2032
Spinal Implants Market CAGR: ~5.50%
Key Spinal Implants Companies: Zimmer Biomet, Medtronic plc., Johnson & Johnson Services, Inc., Stryker Corporation, B. Braun Melsungen AG, NuVasive®, Inc., Orthofix Medical Inc., XTANT MEDICAL, RTI Surgical, Life Spine, Inc., Globus Medical, Captiva Spine, Inc., Medacta International, ATEC Spine, Inc., Advin Health Care, Auxein Medical, Aurora Spine, Spineology Inc., Camber Spine Technologies, LLC, Exactech, Inc.,, and others.

Spinal Implants Market Segmentation
Market Segmentation By Product Type: Spinal Fusion & Fixation Devices [Thoracolumbar Devices, Cervical Fixation Devices, and Interbody Fusion Devices], Motion Preservation/Non-Fusion Devices [Artificial Disc Replacement, Dynamic Stabilization Devices, Annulus Repair Devices, and Others], Vertebral Compression Fracture Treatment Devices/Spine Augmentation Devices [Vertebroplaty Devices, Balloon Kyphoplasty Devices], Spine Biologics [Demineralized Bone Matrix, Bone Morphogenetic Proteins, Allografts, and Others].
Market Segmentation By End-User: Hospitals, Orthopedic Clinics, and others.
Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World.

Which MedTech key players in the spinal implants market are set to emerge as the trendsetter, explore @ https://www.delveinsight.com/report-store/spinal-implants-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr

Table of Contents
1. Spinal Implants Market Report Introduction
2. Spinal Implants Market Executive Summary
3. Competitive Landscape
4. Regulatory Analysis
5. Spinal Implants Market Key Factors Analysis
6. Spinal Implants Market Porter's Five Forces Analysis
7. Spinal Implants Market Layout
8. Spinal Implants Market Company and Product Profiles
9. KOL Views
10. Project Approach
11. About DelveInsight
12. Disclaimer & Contact Us

Contact Us:
Jatin Vimal
jvimal@delveinsight.com
+14699457679
Healthcare Consulting
https://www.delveinsight.com/consulting-services

About DelveInsight
DelveInsight is a premier healthcare business consultant and market research firm, specializing in life sciences. We empower pharmaceutical companies with comprehensive end-to-end solutions designed to enhance performance and drive growth.

Our expert healthcare consulting services offer in-depth market analysis, helping businesses accelerate growth and navigate challenges with actionable, results-driven strategies.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Spinal Implants Market to Grow at a CAGR of 5.50% Through 2032, Fueled by Aging Population, Degenerative Disorders, and Technological Innovation | DelveInsight here

News-ID: 4093005 • Views:

More Releases from DelveInsight

Insulin Resistance Pipeline Insight 2025: Pipeline Drugs, Metabolic Pathway Modulators, and Novel Therapeutics Redefine Future Care | DelveInsight
Insulin Resistance Pipeline Insight 2025: Pipeline Drugs, Metabolic Pathway Modu …
DelveInsight's "Insulin Resistance - Pipeline Insight, 2025" explores over 10+ therapies in development for insulin resistance, a metabolic condition strongly linked to type 2 diabetes, obesity, and cardiovascular disease. Despite lifestyle modification and insulin-sensitizing drugs like metformin being mainstays of management, many patients continue to face poor glycemic control and associated complications, underscoring the need for more effective insulin resistance treatments. The insulin resistance pipeline is broadening with next-generation therapies targeting
Uveal Melanoma Pipeline Insight 2025: 30+ Pipeline Drugs, Targeted Therapies, and Immuno-Oncology Strategies Drive Innovation | DelveInsight
Uveal Melanoma Pipeline Insight 2025: 30+ Pipeline Drugs, Targeted Therapies, an …
DelveInsight's "Uveal Melanoma - Pipeline Insight, 2025" explores over 30+ therapies in development for uveal melanoma, a rare and aggressive intraocular malignancy with high metastatic potential, most commonly to the liver. Despite surgery and radiotherapy being standards for localized disease, patients with metastatic uveal melanoma face limited systemic treatment options, creating significant unmet needs in the uveal melanoma treatment landscape. The uveal melanoma pipeline is diversifying with next-generation targeted therapies, including
Peptic Ulcers Pipeline Insight 2025: Emerging Therapies and Clinical Trials Shaping Next-Generation Peptic Ulcer Disease Treatments | DelveInsight
Peptic Ulcers Pipeline Insight 2025: Emerging Therapies and Clinical Trials Shap …
DelveInsight's "Peptic Ulcers - Pipeline Insight, 2025" examines over 8+ therapies in development for peptic ulcer disease, a condition affecting millions worldwide with peptic ulcer disease symptoms such as abdominal pain, bloating, nausea, and gastrointestinal bleeding. Despite widespread use of existing peptic ulcer disease treatments, including proton pump inhibitors, H2 blockers, and antibiotics for H. pylori eradication, patients with recurrent or complicated peptic ulcers continue to face significant unmet needs,
Vaso-Occlusive Crisis in Sickle Cell Disease: Emerging Therapies, Clinical Trials, and Pipeline Innovations Shaping the Future of Treatment - 2025 | DelveInsight
Vaso-Occlusive Crisis in Sickle Cell Disease: Emerging Therapies, Clinical Trial …
DelveInsight's "Vaso-Occlusive Crisis (VOC) Associated With Sickle Cell Disease - Pipeline Insight, 2025" provides an in-depth analysis of emerging therapies targeting vaso-occlusive crisis (VOC), a severe and recurring complication of sickle cell disease. Despite current standards of care, including hydroxyurea, patients continue to experience frequent vaso occlusive sickle cell crisis, underscoring the urgent need for effective interventions in sickle cell anemia vaso occlusive crisis treatment. The VOC pipeline is diversifying with

All 5 Releases


More Releases for Spinal

Evolving Market Trends In The Spinal Fusion Devices Industry: Advancements In Sp …
The Spinal Fusion Devices Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]._x000D_ _x000D_ What Is the Expected Spinal Fusion Devices Market Size During the Forecast Period?_x000D_ Over the past few years, there has been a significant growth in the spinal fusion devices market. The market is projected
Key Influencer in the Spinal Fusion Devices Market 2025: Rising Spinal Disorder …
What Is the Forecasted Market Size and Growth Rate for the Spinal Fusion Devices Market? The market for spinal fusion devices has experienced significant growth in the past couple of years. Expectations are that it will rise from estimates of $7.85 billion in 2024 to approximately $8.31 billion in 2025, giving us a compound annual growth rate (CAGR) of 5.8%. Factors contributing to this notable expansion during the historical period can
Disposable Spinal Instrument Market: Revolutionizing Spinal Surgery with Hygiene …
Introduction The medical device market has witnessed a surge in demand for disposable instruments, especially in areas where hygiene, precision, and efficiency are paramount. One such sector experiencing rapid growth is the disposable spinal instrument market. Spinal surgeries, being intricate and requiring high precision, have traditionally relied on reusable instruments. However, growing concerns about hygiene, infection control, and surgical efficiency have accelerated the shift toward disposable spinal instruments. These devices not
Endoscopic Spinal Surgery Market: Minimally Invasive Solutions for Spinal Disord …
Global Endoscopic Spinal Surgery Market size was valued at US$ 667 Mn. in 2022 and the total revenue is expected to grow at a CAGR of 7.9% through 2022 to 2029, reaching nearly US$ 1137 Mn. Endoscopic Spinal Surgery Market Overview: Maximize Market Research is a research firm that has published a detailed analysis of the "Endoscopic Spinal Surgery Market". MMR in-depth market assessments in research reports consider significant technological advancements in
Spinal Resilience: Acute Spinal Cord Injury Drug Pipeline Landscape (2023)
Market Outlook: Charting Progress: Acute Spinal Cord Injury Drug Pipeline Landscape (2023) The Acute Spinal Cord Injury Drug Pipeline Landscape sets its sights on a decade of advancements poised to redefine the trajectory of spinal resilience. This comprehensive outlook explores the unfolding strategies, innovations, and breakthroughs that promise to revolutionize the landscape of acute spinal cord injury treatment. Market Drivers: Neuroregeneration on the Horizon: At the forefront of the Acute Spinal Cord Injury Drug
Spinal Laminoplasty Market - Revolutionizing spinal care with minimally invasive …
Newark, New Castle, USA: The "Spinal Laminoplasty Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Spinal Laminoplasty Market: https://www.growthplusreports.com/report/spinal-laminoplasty-market/8601 This latest report researches the industry structure, sales, revenue,